Deborah Ashby, the School of Public Health, Imperial College Londo Frank Bretz, Novartis Pharma AG Maria Ciarleglio, Yale School of Public Health Brian Hobbs, University of Texas at Austin Ying Yuan, The University of Texas MD Anderson Cancer Center Jeni Zhou, Amgen